Case Report
Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
Volume 25 | Issue 6 | November-December 2015
Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.